Aldara (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Aldara drug offered from Valeant Pharmaceuticals North America LLC. This Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | imiquimod |
| SUBSTANCE NAME: | IMIQUIMOD |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-02-27 |
| END MARKETING DATE: | 0000-00-00 |
Aldara HUMAN PRESCRIPTION DRUG Details:
| Item Description | Aldara from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/g) |
| START MARKETING DATE: | 1997-02-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 99207-260_51972e26-3c53-4675-952e-fc6679a92190 |
| PRODUCT NDC: | 99207-260 |
| APPLICATION NUMBER: | NDA020723 |
Other IMIQUIMOD Pharmaceutical Manufacturers / Labelers:
